2013 Annual Meeting Posters: Sunday, May 20, 2012

Posters Home | Monday>>

	indicates a poster featured in a Poster Tour: (ticketed session with complimentary but limited registration)
		Sunday, May 19, 2013, 11:00 - 11:45 AM: Esophageal and Stomach Monday, May 20, 2013, 11:00 - 11:45 AM: HPB Tuesday, May 21, 2013, 11:00 - 11:45 AM: Small Bowel and Colon-Rectal
	indicates a Poster of Distinction.

Sunday, May 19, 2013
Basic: Colon-Rectal
Su1794	Effect of Instrument Type on Transanal Endoscopic Microsurgery (TEM) Learning Curves Ezra N. Teitelbaum, Northwestern University, Chicago, IL
Basic: Esophageal
Su1795	Growth Factor Receptors in the Gastrointestinal Tract of the Rat: New Targets for Improved Anastomotic Healing? Daniel Georg Drescher, University of Mainz, Mainz Germany
Basic: Pancreas
Su1796	Histone Deacetylase Inhibition (HDAC) by Vorinostat Sensitizes Pancreatic Cancer Cells to TRAIL Induced Cell Death Rohit Chugh, Surgery, Basic and Translational Research Lab, Minneapolis, MN
Su1797	Concepts for the Periampullary Carcinoma Enigma from Clinico-Pathologic Analysis of 198 Patients Peter Bronsert, Pathological Institute, University of Freiburg, Freiburg Germany
Clinical: Biliary
Su1590	Laparoscopic Cholecystectomy in Patients on Clopidogrel: Is It Safe? Richard Frazee, Surgery, Scott & White Healthcare, Temple, TX
Su1591	Diagnostic Accuracy of Preoperative Multidetector-Row Computed Tomography Imaging in Predicting Microscopic Curative Resection of Hepatobiliary and Pancreatic Malignancy: A Prospective Multi-Institutional Study Kazuaki Shimada, Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Tokyo Japan
Su1592	Elevated Perioperative Serum CA 19-9 Level Is an Independent Predictor of Poor Outcome in Patients with Resectable Cholangiocarcinoma Naru Kondo, Surgery, Hiroshima Univ, Hiroshima, Hiroshima Japan
Su1593	Stapling the Cystic Duct During Laparoscopic Cholecystectomy Results in Increased Rates of Unintended Post-Operative ERCP Irene Epelboym, Surgery, Columbia University Medical Center, New York, NY
Su1594	Diagnostic Utility of Magnetic Resonance Cholangiopancreatography (MRCP) in Patients with Intermediate Probability of Cholidocholithiasis Hari P. Sayana, University of Missouri Kansas City School of Medicine, Mission, KS
Su1595	Trends in Liver Biochemistries: Are They a Better Predictors Than MRCP in Evaluation of Patients with Intermediate Probability of Choledocholithiasis? Hari P. Sayana, University of Missouri Kansas City School of Medicine, Mission, KS
Su1596	Procedure Timing in Cholecystectomy Influence Outcome in Patients Admitted for Acute Gallstone Disease Muhammad Asad Khan, Staten Island University Hospital, Staten Island, NY
Su1597	Gallbladder Perforation and Grade Do Not Affect Survival in Patients with Incidental Gallbladder Cancer Vadim P. Koshenkov, Surgery, University of Miami, Miami, FL
Su1598	Insurance Impacts Biliary Disease: A National Study Elizaveta Ragulin-Coyne, Department of Surgery, Surgical Outcomes Analysis & Research, University of Massachusetts Medical School, Worcester, MA
Clinical: Colon-Rectal
Su1600	Extensive Abdominal Wall Necrotizing Fasciitis and Fournier’s Gangrene Complicating Perforated Appendicitis Basem Azab, Surgery, Staten Island University Hospital, Staten Island, NY
Su1601	Robotics in Colorectal Surgery: A Paradigm Shift? Fatima G. Wilder, Surgery, UMDNJ - University Hospital, Newark, NJ
Su1602	Cancer-Associated Inflammation in a Cohort of Colorectal Cancer Patients with Inflammatory Bowel Disease Graeme JK Guthrie, Academic Department of Surgery, University of Glasgow, Glasgow United Kingdom
Su1604	Outcomes for Robotic-Assisted Rectopexy With or Without Sigmoid Colon Resection for Rectal Prolapse Hyuma Leland, Surgery, University of California, San Diego, San Diego, CA
Su1605	Anastomotic Leak Following Anterior Resection for Rectal Cancer: Does the Presence of a Defunctioning Stoma Reduce the Burden of a Leak? Wissam J. Halabi, Surgery, University of California-Irvine , Orange , CA
Su1606	Delay in Management: A Nationwide Study of Appendicitis in Patients with Cystic Fibrosis Allan Mabardy, Saint Elizabeth's Medical Center, Boston, MA
Su1607	Proctological Problems in Relation to Chemotherapy Danny De Looze, Gastroenterology, University Hospital Gent, Gent Belgium
Su1608	Peritoneal Expression of Matrilysin Helps Identify Early Post-Operative Recurrence of Colorectal Cancer Cristina Fiorani, Tor Vergata, Rome Italy
Su1609	High-Dose Circumferential Chemodenervation (HDCC) of the Internal Anal Sphincter: A New Treatment Modality for Uncomplicated Chronic Anal Fissure Porter H. Glover, Internal Medicine, University of Mississippi Medical Center, Ridgeland, MS
Su1610	Medication Use and the Risk of Diverticular Complications: A Systematic Review Charlotte Kvasnovsky, Department of Colorectal Surgery, Department of Surgery, King's College Hospital, University of Maryland Medical Center, London United Kingdom
Su1611	Postoperative Bleeding After Colon and Rectal Surgery by Preoperative Diagnosis: A Nationwide Analysis Nitin Kumar, Division of Gastroenterology, Brigham & Women's Hospital, Boston, MA
Su1612	Long Term Outcomes of Continent Ileostomy Created in the Pediatric Age Group Erman Aytac, Department of Colorectal Surgery , Digestive Disease Institute Cleveland Clinic, Clevaland, OH
Su1613	Risk Factors for Mortality for Surgical Clostridium Difficile Colitis: A Review and Meta-Analysis Stephanie G. Wood, Surgery, Yale School of Medicine, New Haven, CT
Su1614	Predictors of Bleeding, Reoperation, and Mortality After Colon and Rectal Surgery by Preoperative Diagnosis: A Nationwide Analysis Nitin Kumar, Division of Gastroenterology, Brigham & Women's Hospital, Boston, MA
Su1615	Risk Factors for Urinary Tract Infection in Rectal Surgery Patients Janet Tien-Ming Lee, Department of Surgery, Division of Colon and Rectal Surgery, University of Minnesota, Minneapolis, MN
Su1616	Nationwide Analysis of Postoperative Bleeding After Colon and Rectal Surgery over the Past Decade: Incidence, Intervention, and Mortality Nitin Kumar, Division of Gastroenterology, Brigham & Women's Hospital, Boston, MA
Clinical: Esophageal
Su1617	Most Patients with Persistent Symptoms on Acid-Suppressive Therapy Do Not Have Reflux as a Cause of Their Symptoms: a Single Center Study Using Ambulatory Impedance-Ph Study Pradeep kumar Pallati, Creighton University, Omaha, NE
Su1618	Restaging PET-CT After Neoadjuvant Chemoradiotherapy Can Prevent Non-Curative Surgical Interventions in Esophageal Cancer Patients Martinus C.J. Anderegg, Surgery, Academic Medical Center, Amsterdam Netherlands
Su1619	Conversion of Fundoplication to Roux-en-Y Gastric Bypass: Long-Term Results Daniel B. Leslie, Department of Surgery, University of Minnesota, Minneapolis, MN
Su1620	Esophageal Cancer in the Young: A Population-Based Analysis of 1,095 Patients Attila Dubecz, Surgery, Klinikum Nurnberg, Nurnberg Germany
Su1621	Prevalence of Gastroesophageal Reflux in Chronic Obstructive Pulmonary Disease Patients Fernando A. M. Herbella, Department of Surgery, Federal University of Sao Paulo, Sao Paulo, sao paulo Brazil
Su1622	Celiac Nodal Status as Determined by Laparoscopic Gastric Ischemic Preconditioning Is Prognostic in Locally-Advanced Esophageal Cancer and May Determine Necessity for Completion Esophagectomy Sabha Ganai, Surgery, Surgery, The University of Chicago Medicine, NorthShore University HealthSystem, Chicago, IL
Su1623	POEM-Based Endoscopic Treatment of Zenker's Diverticulum: Minimal Incision Cricopharyngeal Myotomy (CPM) Luke McCrone, Internal Medicine, Mayo Clinic Florida, Jacksonville, FL
Su1624	Postoperative Management of Nutrition After Ivor Lewis Esophagogastrectomy for Cancer Laura Trujillo, Mayo Clinic, Rochester, MN
Su1625	High-Resolution Impedance Manometry Findings in Patients with Epiphrenic Diverticulum Se Ryung Yamamoto, Creighton University, Omaha, NE
Su1626	Surgical Management of Esophageal Perforation: A 10-Year Experience Paul Goldsmith, Manchester Royal Infirmary, Manchester United Kingdom
Su1627	Sustained Improvement in GERD-HRQL, Patient Satisfaction, and Anti-Secretory Drug Use 10-Years After Stretta for Medically Refractory GERD Mark David Noar, The Heartburn and Reflux Center, Endoscopic Microsurgery Associates, Towson, MD
Su1628	Bibliometric Analysis of the Scientific Publications about Gastroesophageal Reflux Disease (GERD) Between 1954 and 2011 Shahin Ayazi, Surgery, University of Rochester, Rochester , NY
Su1629	The Better Definition of Nodal Staging in the 7th Edition of TNM Manual Does Not Predict Survival or Translates Into Better Prognosticating Ability in Oesophago-Gastric Junctional Adenocarcinoma Ramesh Yap Kannan, Minimal Access Surgery, Royal Gwent Hospital, Newport United Kingdom
Su1631	Does Surgery Have a Role in the Treatment of Small Cell Cancer of the Esophagus? Moshim Kukar, Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY
Su1632	Dissatisfaction After Laparoscopic Heller Myotomy Sharona B. Ross, General Surgery, Florida Hospital Tampa, Tampa, FL
Su1633	A Single Institution’s Journey with Heller Myotomy: Is the Laparo-Endoscopic Single Site (LESS) Approach Best? Sharona B. Ross, General Surgery, Florida Hospital Tampa, Tampa, FL
Su1635	Surgical Treatment for Achalasia: A NSQIP Analysis. Stephanie G. Wood, Surgery, Yale School of Medicine, New Haven, CT
Clinical: Hepatic
Su1636	Difference in Outcomes Between Right and Left Hepatectomy in Patients Undergoing Hepatic Resection Mashaal Dhir, University of Nebraska Medical Center, Omaha, NE
Su1639	Modified FOLFOX6 and Bevacizumab as Neoadjuvant Chemotherapy for Patients with Potentially Curable Bilobar Liver Metastases from Colorectal Cancer Atsuyuki Maeda, Digestive surgery, Ogaki Municipal Hospital, Ogaki, Gifu Japan
Su1640	Hepatectomy for Liver Metastases from Gastric and Esophageal Cancer: Tumor Biology and Surgical Results Define Outcome Andreas Andreou, Department of General, Visceral and Transplant Surgery , Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin Germany
Su1641	Portal Venous Thrombosis After Distal Pancreatectomy: Risk Factors and Outcomes Ashwin S. Kamath, General Surgery, Mayo Clinic, Rochester MN, Rochester, MN
Clinical: Pancreas
Su1642	Positron Emission Tomography (PET) Has Limited Utility in Preoperative Staging of Pancreatic Adenocarcinoma Peter Einersen, Surgery, Columbia University Medical Center, New York, NY
Su1644	Human Equilibrate Nucleoside Transporter 1 Expression Predicts Survival of Pancreatic Cancer Patients Trated with Gemcitabine-Based Adjuvant Chemotherapy After Resection Toshiyuki Moriya, Surgery, Okitama Public General Hospital, Yamagata Japan
Su1645	The Effect of Preoperative Renal Insufficiency on Postoperative Outcomes Following Pancreatic Resection: A Single Institution Experience of 1061 Consecutive Patients Malcolm Hart Squires, III, Department of Surgery, Division of Surgical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA
Su1647	Clinicopathologic Features Influencing Survival in Patients with Resected Pancreatic Adenocarcinoma by Pancreaticoduodenectomy Cynthia Weber, Surgical Oncology, Loyola University Medical Center, Maywood, IL
Su1648	A Comparison of the 2-Year Longitudinal Impact of Surgical Versus Endoscopic Pancreatic Pseudocyst Drainage on Healthcare Utilization and Morbidity Jennifer Marie Whittington, University of Kentucky, Lexington, KY
Su1649	Histological Degree of Islet Cells at Cut Margin Indicates Postoperative Glucose Metabolism Insufficiency After Distal Pancreatectomy Masahiko Morifuji, Internal Medicine, Surgery, Sanmu Medical Center, Hiroshima University, Chiba Japan
Su1650	Preoperative Prediction of the “High-Risk Pancreas” by Artificial Neuronal Network Analysis of over 450 Pancreatoduodenectomies Hryhoriy Lapshyn, Clinic for General and Visceral Surgery, University of Freiburg Medical Center, Freiburg im Breisgau Germany
Su1651	Activation of Pancreatic Enzyme Plus Bacterial Infection Plays an Important Role in the Pathogenic Mechanism of Clinically Relevant POPF After Pancreaticoduodenectomy Kenichiro Uemura, Surgery, Hiroshima University, Hiroshima Japan
Su1652	Evolution of the Treatment of Gastroduodenal Artery Pseudoaneurysms and Mesenteric Arterial Hemorrhage Following Pancreaticoduodenectomy Aram N. Demirjian, Surgery, University of California-Irvine, Orange, CA
Su1653	Trends in Pancreatic Surgery: Indications, Operative Techniques and Postoperative Outcome of 1120 Pancreatic Resections Frank Makowiec, Dept. of Surgery, University of Freiburg, Freiburg Germany
Su1655	Is Frozen Section Histopathology of Any Value in Patients Undergoing Resection of Intraductal Papillary Mucinous Neoplasms? Daniel Joyce, Department of General Surgery, Section of Surgical Oncology/HPB, Cleveland Clinic Foundation, Cleveland , OH
Su1656	Endoscopic and Surgical Alternatives to Pancreaticoduodenectomy and Distal Pancreatectomy Jennifer Kay Plichta, Surgery Department, Loyola University Medical Center, Oak Park, IL
Su1657	Central Pancreatic Resection Vichin Puri, Hepatobiliary and Pancreatic Surgery, Cedars-Sinai Medical Center, Los Angeles, CA
Su1658	Impact of Pancreatoduodenectomy Complications on Adjuvant Therapy and Long-Term Outcomes for Pancreatic Adenocarcinoma Janak A. Parikh, Surgery, Indiana University Hospital, Indianapolis, IN
Su1659	Impact of Laparoscopic Approach on Postoperative Pain and Opioid Consumption After Pancreatoduodenectomy Naru Kondo, Mayo Clinic, Rochester, MN
Su1660	Pre-Operative Lovenox Does Not Increase Blood Loss During Pancreaticoduodenectomy Compared to Heparin William C. Conway, II, Surgical Oncology, Ochsner Medical Center, New Orleans, LA
Clinical: Small Bowel
Su1661	Risk Factors for Postoperative Complications After Ileocecal Resection in Patients with Crohn’s Disease Michael Simon Kasparek, Department of Surgery, Ludwig-Maximilians-University Munich, Munich Germany
Su1662	The First Validated Nomogram to Predict 30-Day Mortality Following Surgery for Small Bowel Obstruction Wissam J. Halabi, Surgery, University of California-Irvine , Orange , CA
Su1663	Serum C-Reactive Protein as Predictor of Recurrence in Patients Undergoing Ileo-Colonic Resection for Crohn’s Disease: Results of a Longitudinal Prospective Study Edoardo Iaculli, Tor Vergata, Rome Italy
Su1664	Predictors of Recurrence and Post Recurrence Survival in Patients with Resected Ampullary Adenocarcinoma Irene Epelboym, Surgery, Columbia University Medical Center, New York, NY
Su1665	Adenomas of the Ampulla of Vater: A Comparison of Outcomes of Operative and Endoscopic Resections Edwin Onserio Onkendi, Surgery, Mayo Clinic, Rochester, MN, Rochester, MN
Su1666	Clinical Outcomes for Neuroendocrine Tumors of the Duodenum and Ampulla of Vater: A Population-Based Study Reese W. Randle, General Surgery, Wake Forest Baptist Health, Winston-Salem, NC
Su1667	Laparoscopic Vs. Open Bilateral Inguinal Hernia Repair: A NSQIP Analysis Muhammad Asad Khan, Staten Island University Hospital, Staten Island, NY
Clinical: Stomach
Su1668	Outcome of the Surgical Treatment of Gastric Cancer After Inauguration of the Neoadjuvant Concept Using a Systematic Multicenter Prospective Clinical Observational Study Frank Meyer, Department of Surgery, University Hospital, Magdeburg Germany
Su1669	The Tolerance to Volume Load, But Not the Reservoir or Emptying Capacity, Reflects the Patients’ Living States After Gastrectomy Koji Nakada, Surgery, The Jikei University School of Medicine, Tokyo Japan
Su1670	Predictors of Cardiopulmonary Complications Following Bariatric Surgery John M. Morton, Surgery, Stanford University, Stanford, CA
Su1671	Long Term Recurrence and Survival Rates in Gastrointestinal Stromal Tumours (GISTs) Treated by Minimally Invasive Surgery Evangelos Sotiris Photi, Medicine, Norwich Medical School, Norwich United Kingdom
Su1672	Predictors of Lymph Node Involvement in T1 Gastric Carcinoma Rima Ahmad, Surgery, Massachusetts General Hospital, Boston, MA
Su1674	Laparoscopic Sleeve Gastrectomy as a Revision from Laparoscopic Adjustable Gastric Band: One Year Results Melissa Bagloo, Surgery, Columbia University, New York, NY
Translational Science: Colon-Rectal
Su2127	Wild Homozygous VEGF-A and Cox-2 Gene Polymorphisms Are Associated to Worst Prognosis in Patients with Colorectal Cancer (CRC) Michele T. Tomitão, Gastroenterology, University of São Paulo, São Paulo, SP Brazil
Su2128	Age, Gender, and Folate Metabolism Polymorphisms Influence on Gene Promoter Methylation in CRC Patients Roberto Spisni, Surgical Pathology, University of Pisa, Italy, Pisa Italy
Translational Science: Esophageal
Su2129	Whole Exome Sequencing Revealed Putative Driver Mutations in Esophageal Cancer Peter P. Grimminger, Department of General-, Visceral- and Tumor surgery , University Clinic Cologne, Cologne Germany
Translational Science: Other
Su2130	Outcomes of Lung Transplant Patients with Severe GI Complications Jennifer M. Hanna, General Surgery, Duke University Medical Center, Durham, NC
Su2131	Per-Umbilical Laparoscopic Access Rodrigo Arrangoiz, Surgery, American British Cowdray Medical Center, D.F., D.F. Mexico
Translational Science: Small Bowel
Su2132	Dissociation of Activity of Ileal and Liver FXR Mediates Metabolic Effects in a Rodent Model of Bariatric Surgery Stefano Fiorucci, Medicina Clinica e Sperimentale, University of Perugia, Perugia Italy